The Patient Reported Outcome Indices F_AO1_R Multiple Sclerosis    PRIMUS    IH1_Z AH0 D_IH0_Z_IY1_Z S_P_AH0_S_IH1_F_IH0_K P_EY1_SH_AH0_N_T R_IY2_P_AO1_R_T_AH0_D AW1_T_K_AH2_M K_W_EH2_S_CH_AH0_N_EH1_R W_IH1_CH M_EH1_ZH_ER0_Z DH_AH0 K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F    QoL    AH1_V P_EY1_SH_AH0_N_T_S S_AH1_F_ER0_IH0_NG F_R_AH1_M M_AH1_L_T_AH0_P_AH0_L S_K_L_ER0_OW1_S_AH0_S    The M_EH1_ZH_ER0 K_AH0_N_T_EY1_N_Z AE1_N AH0_S_EH1_S_M_AH0_N_T AH1_V K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F    AE0_K_T_IH1_V_IH0_T_IY0 L_IH2_M_IH0_T_EY1_SH_AH0_N_Z AH0_N_D S_IH1_M_P_T_AH0_M_Z HH_AY1_ER0 S_K_AO1_R AA1_N EH1_N_IY0 AO1_R AO1_L AH1_V DH_IY1_Z S_K_EY1_L_Z IH1_N_D_IH0_K_EY2_T_S AH0 L_OW1_ER0 K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F D_UW1 T_UW1 DH_AH0 D_IH0_Z_IY1_Z    First P_AH1_B_L_IH0_SH_T IH0_N 2009 B_AY1 Galen Research AH0_N_D F_AH1_N_D_AH0_D B_AY1 Novartis Pharmaceuticals    DH_AH0 PRIMUS W_AA1_Z D_IH0_V_EH1_L_AH0_P_T IH0_N AO1_R_D_ER0 T_UW1 P_R_AH0_V_AY1_D AH0 M_AO1_R HH_OW0_L_IH1_S_T_IH0_K V_Y_UW1 AH1_V DH_AH0 IH2_M_P_AE1_K_T AH1_V MS AA1_N AH0 P_EY1_SH_AH0_N_T    The M_EH1_ZH_ER0 HH_AE1_Z TH_R_IY1 S_K_EY1_L_Z    K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F    S_IH1_M_P_T_AH0_M_Z AH0_N_D AE0_K_T_IH1_V_IH0_T_IY0 L_IH2_M_IH0_T_EY1_SH_AH0_N_Z    W_IH1_CH AA1_R D_IH0_Z_AY1_N_D T_UW1 B_IY1 Y_UW1_Z_D T_AH0_G_EH1_DH_ER0 AO1_R AE1_Z standalone M_EH1_ZH_ER0_Z    The QoL AH0_N_D S_IH1_M_P_T_AH0_M S_K_EY1_L_Z AA1_R B_EY1_S_T AA1_N S_IH1_M_P_AH0_L S_T_EY1_T_M_AH0_N_T_S W_IH1_DH dichotomous R_IH0_S_P_AA1_N_S AA1_P_SH_AH0_N_Z    Each S_K_EY1_L HH_AE1_Z AH0 T_OW1_T_AH0_L S_K_AO1_R W_IH1_CH R_EY1_N_JH_AH0_Z F_R_AH1_M T_UW1 22 The AE0_K_T_IH1_V_IH0_T_IY0 S_K_EY1_L IH1_Z B_EY1_S_T AA1_N 15 S_T_EY1_T_M_AH0_N_T_S D_IH0_S_K_R_AY1_B_IH0_NG T_AE1_S_K_S Patients AA1_R AE1_S_K_T T_UW1 R_EY1_T DH_EH1_R AH0_B_IH1_L_AH0_T_IY2 T_UW1 P_ER0_F_AO1_R_M DH_IY1_Z T_AE1_S_K_S AA1_N AH0 S_K_EY1_L F_R_AH1_M T_UW1 The T_OW1_T_AH0_L S_K_AO1_R AH1_V DH_AH0 AE0_K_T_IH1_V_IH0_T_IY0_Z S_EH1_K_SH_AH0_N R_EY1_N_JH_AH0_Z F_R_AH1_M T_UW1 30    Since DH_AH0 D_IH0_V_EH1_L_AH0_P_M_AH0_N_T AH1_V DH_AH0 PRIMUS    IH1_T HH_AE1_Z B_IH1_N T_R_AE0_N_Z_L_EY1_T_AH0_D IH1_N_T_UW0 S_EH1_V_ER0_AH0_L L_AE1_NG_G_W_AH0_JH_AH0_Z IH2_N_K_L_UW1_D_IH0_NG Canadian English AH0_N_D French    French    German    Italian    Spanish    Swedish    US English     Australian AH0_N_D New Zealand English AH0_N_D US Spanish    This HH_AE1_Z AH0_L_AW1_D R_IY1_S_ER0_CH_ER0_Z T_UW1 K_AA1_N_D_AH0_K_T S_T_AH1_D_IY0_Z F_AO1_R S_P_AH0_S_IH1_F_IH0_K P_AA2_P_Y_AH0_L_EY1_SH_AH0_N_Z    S_AH1_CH AE1_Z Spain    AH0_N_D Europe    The PRIMUS HH_AE1_Z B_IH1_N Y_UW1_T_AH0_L_AY2_Z_D IH0_N K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z W_IH1_CH AH0_S_EH1_S DH_AH0 EH1_F_IH0_K_AE2_S_IY0 AH1_V AH0 T_R_IY1_T_M_AH0_N_T AO1_R M_EH2_D_AH0_K_EY1_SH_AH0_N If AH0 P_EY1_SH_AH0_N_T EH1_S S_K_AO1_R AA1_N DH_AH0 PRIMUS CH_EY1_N_JH_AH0_Z AE1_F_T_ER0 AH0 T_R_AY1_AH0_L HH_AE1_Z T_EY1_K_AH0_N P_L_EY1_S    IH1_T IH1_Z IH2_N_F_ER1_D DH_AE1_T DH_AH0 T_R_AY1_AH0_L HH_AE1_Z HH_AE1_D AE1_N IH0_F_EH1_K_T AA1_N DH_AH0 P_EY1_SH_AH0_N_T EH1_S K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F PRIMUS HH_AE1_Z B_IH1_N Y_UW1_Z_D T_UW1 AH0_S_EH1_S DH_AH0 EH1_F_IH0_K_AE2_S_IY0 AH1_V fingolimod      AH0_N_D rivastigmine   